BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 29
• 30

• BioForest

  BioLife Solutions, Inc. Granted European Biopreservation Patent; Expands Protection of Key Intellectual Property Related to Minimizing Cell Death

  December 8, 2008

   · 

  2 min read
• FDA

  FDA Approves GlaxoSmithKline Tetanus, Diphtheria, Whooping Cough Vaccine, BOOSTRIX(R), for Adults

  December 8, 2008

   · 

  6 min read
• Business

  BioWa Licenses POTELLIGENT(R) Technology to GlaxoSmithKline for Use in Antibody Development and Commercialization

  December 8, 2008

   · 

  2 min read
• Drug Development

  GlaxoSmithKline Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study

  December 8, 2008

   · 

  12 min read
• Drug Development

  Cytokinetics, Inc. Announces Clinical Trial Data Regarding SB-743921 Presented at the 2008 Annual Meeting of American Society of Hematology

  December 8, 2008

   · 

  1 min read
• Drug Development

  GlaxoSmithKline’s Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL)

  December 8, 2008

   · 

  11 min read
• Drug Development

  GlaxoSmithKline, Valeant Pharmaceuticals International Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy

  December 8, 2008

   · 

  6 min read
• Deals

  GlaxoSmithKline Extends Tender Offer for Genelabs Technologies, Inc.

  December 8, 2008

   · 

  2 min read